ScoreComparison
Why is AbCellera Biologics, Inc. ?
1
The company has declared Negative results for the last 10 consecutive quarters
- ROCE(HY) Lowest at -16.81%
- DEBT-EQUITY RATIO (HY) Highest at -39.26 %
- OPERATING PROFIT(Q) Lowest at USD -69.04 MM
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 38.56%, its profits have risen by 2.3%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is AbCellera Biologics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
AbCellera Biologics, Inc.
67.94%
-0.09
78.10%
S&P 500
16.08%
0.62
19.30%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-46.89%
EBIT Growth (5y)
-194.01%
EBIT to Interest (avg)
-96.09
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.61
Sales to Capital Employed (avg)
0.04
Tax Ratio
20.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
53.52%
ROCE (avg)
43.54%
ROE (avg)
8.32%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.12
EV to EBIT
-2.16
EV to EBITDA
-2.49
EV to Capital Employed
1.26
EV to Sales
15.96
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-58.25%
ROE (Latest)
-17.81%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend11What is working for the Company
NET PROFIT(HY)
Higher at USD -91.85 MM
RAW MATERIAL COST(Y)
Fallen by -103.71% (YoY
NET SALES(Q)
At USD 8.96 MM has Grown at 37.62%
-10What is not working for the Company
ROCE(HY)
Lowest at -16.81%
DEBT-EQUITY RATIO
(HY)
Highest at -39.26 %
OPERATING PROFIT(Q)
Lowest at USD -69.04 MM
PRE-TAX PROFIT(Q)
Lowest at USD -68.77 MM
NET PROFIT(Q)
Lowest at USD -57.12 MM
EPS(Q)
Lowest at USD -0.19
Here's what is working for AbCellera Biologics, Inc.
Net Sales
At USD 8.96 MM has Grown at 37.62%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Raw Material Cost
Fallen by -103.71% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for AbCellera Biologics, Inc.
Debt-Equity Ratio
Highest at -39.26 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Profit
Lowest at USD -69.04 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Pre-Tax Profit
Lowest at USD -68.77 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -57.12 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -0.19
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
